Drug Shortage Report for SANDOZ DEFERASIROX

Last updated on 2023-10-24 History
Report ID 193710
Drug Identification Number 02464470
Brand name SANDOZ DEFERASIROX
Common or Proper name DEFERASIROX
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) DEFERASIROX
Strength(s) 500MG
Dosage form(s) TABLET FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 28DT
ATC code V03AC
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-06-05
Estimated end date 2023-10-27
Actual end date 2023-10-23
Shortage status Resolved
Updated date 2023-10-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2023-10-24 English Compare
v17 2023-10-23 French Compare
v16 2023-10-23 English Compare
v15 2023-10-02 French Compare
v14 2023-10-02 English Compare
v13 2023-09-25 French Compare
v12 2023-09-25 English Compare
v11 2023-09-19 French Compare
v10 2023-09-19 English Compare
v9 2023-09-11 French Compare
v8 2023-09-11 English Compare
v7 2023-07-31 French Compare
v6 2023-07-31 English Compare
v5 2023-06-06 English Compare
v4 2023-06-05 French Compare
v3 2023-06-05 English Compare
v2 2023-06-05 French Compare
v1 2023-06-05 English Compare

Showing 1 to 18 of 18